Cargando…

Tumor necrosis factor receptor‐2 signaling pathways promote survival of cancer stem‐like CD133(+) cells in clear cell renal carcinoma

Clear cell renal cell carcinoma (ccRCC) contains cancer stem‐like cells (CSCs) that express CD133 (ccRCC‐CD133(+)). CSCs are rarely in cell cycle and, as nonproliferating cells, resist most chemotherapeutic agents. Previously, we reported that tumor necrosis factor receptor‐2 (TNFR2) signaling promo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bradley, John R., Wang, Jun, Pacey, Simon, Warren, Anne Y., Pober, Jordan S., Al‐Lamki, Rafia S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003657/ https://www.ncbi.nlm.nih.gov/pubmed/32123862 http://dx.doi.org/10.1096/fba.2019-00071

Ejemplares similares

Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma
por: Al-Lamki, Rafia S, et al.
Publicado: (2016)

Tumor Necrosis Factor Receptor 2: Its Contribution to Acute Cellular Rejection and Clear Cell Renal Carcinoma
por: Wang, Jun, et al.
Publicado: (2013)

Human Organ Culture: Updating the Approach to Bridge the Gap from In Vitro to In Vivo in Inflammation, Cancer, and Stem Cell Biology
por: Al-Lamki, Rafia S., et al.
Publicado: (2017)

TL1-A can engage death receptor-3 and activate NF-kappa B in endothelial cells
por: Wang, Jun, et al.
Publicado: (2014)

Tubular epithelial cells in renal clear cell carcinoma express high RIPK1/3 and show increased susceptibility to TNF receptor 1-induced necroptosis
por: Al-Lamki, R S, et al.
Publicado: (2016)

TNFR2 ligation in human T regulatory cells enhances IL2-induced cell proliferation through the non-canonical NF-κB pathway
por: Wang, Jun, et al.
Publicado: (2018)

Mesenchymal stem cell-like properties of CD133(+) glioblastoma initiating cells
por: Pavon, Lorena Favaro, et al.
Publicado: (2016)

CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells
por: Barrantes-Freer, Alonso, et al.
Publicado: (2015)

PKH(high)/CD133+/CD24− Renal Stem-Like Cells Isolated from Human Nephrospheres Exhibit In Vitro Multipotency
por: Bombelli, Silvia, et al.
Publicado: (2020)

The effect and molecular mechanism of hypoxia on proliferation and apoptosis of CD133(+) renal stem cells
por: Liu, Hong, et al.
Publicado: (2021)

Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme
por: Kase, Marju, et al.
Publicado: (2013)

CD133 Positive Embryonal Rhabdomyosarcoma Stem-Like Cell Population Is Enriched in Rhabdospheres
por: Walter, Dagmar, et al.
Publicado: (2011)

Ecto-5′-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells
por: Song, Lei, et al.
Publicado: (2017)

CD133: a stem cell biomarker and beyond
por: Li, Zhong
Publicado: (2013)

Prostate Cancer Stem Cells: The Role of CD133
por: Yang, Jianhui, et al.
Publicado: (2022)

Retraction: The effect and molecular mechanism of hypoxia on proliferation and apoptosis of CD133+ renal stem cells
Publicado: (2023)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality?
por: Yu, Xiazhen, et al.
Publicado: (2011)

Suitability of CD133 as a Marker for Cancer Stem Cells in Melanoma
por: Korn, Philippe, et al.
Publicado: (2021)

Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells
por: Xue, Zhan-Xiong, et al.
Publicado: (2014)

Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma
por: Liu, Chao Lien, et al.
Publicado: (2020)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

CD133 Is Associated with Increased Melanoma Cell Survival after Multikinase Inhibition
por: Simbulan-Rosenthal, Cynthia M., et al.
Publicado: (2019)

Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer
por: Ehteram, Hassan, et al.
Publicado: (2022)

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
por: Rountree, C. Bart, et al.
Publicado: (2011)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

Autocrine interleukin-23 promotes self-renewal of CD133(+) ovarian cancer stem-like cells
por: Wang, Dan, et al.
Publicado: (2016)

Role of CD133/NRF2 Axis in the Development of Colon Cancer Stem Cell-Like Properties
por: Park, Jimin, et al.
Publicado: (2022)

Potential Role of CD133 Expression in the Susceptibility of Human Liver Cancer Stem-Like Cells to TRAIL
por: Lee, Su-Hoon, et al.
Publicado: (2016)

ID proteins promote the survival and primed-to-naive transition of human embryonic stem cells through TCF3-mediated transcription
por: Jiang, Haibin, et al.
Publicado: (2022)

CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy
por: Ke, Chien-Chih, et al.
Publicado: (2012)

CD133(+)CD24(lo) defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype
por: Paschall, Amy V., et al.
Publicado: (2016)

In Vitro Identification and Characterization of CD133(pos) Cancer Stem-Like Cells in Anaplastic Thyroid Carcinoma Cell Lines
por: Zito, Giovanni, et al.
Publicado: (2008)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

The Efficacy of Sunitinib Treatment of Renal Cancer Cells Is Associated with the Protein PHAX In Vitro
por: Al-Lamki, Rafia S., et al.
Publicado: (2020)

THE CD133-POSITIVE COLON CANCER CELL PHENOTYPE IS MORE INTERACTIVE WITH THE TUMOR MICROENVIRONMENT COMPARED TO CD133-NEGATIVE CELL
por: Chao, Celia, et al.
Publicado: (2011)

Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma
por: An, Josiah, et al.
Publicado: (2022)

Role of CD133 Molecule in Wnt Response and Renal Repair
por: Brossa, Alessia, et al.
Publicado: (2018)

Cancer stem cells CD133 and CD24 in colorectal cancers in Northern Iran
por: Nosrati, Anahita, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mof4kdtueclt4j5gte0p03u5ut